IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 223 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,159 | -56.2% | 16,079 | -7.7% | 0.02% | -66.2% |
| Q3 2022 | $167,000 | -42.2% | 17,419 | +0.2% | 0.06% | -59.6% |
| Q1 2022 | $289,000 | +21.4% | 17,380 | +39.5% | 0.16% | +15.0% |
| Q4 2021 | $238,000 | -19.9% | 12,462 | +3.5% | 0.14% | -25.1% |
| Q3 2021 | $297,000 | +40.8% | 12,035 | +56.9% | 0.19% | -33.0% |
| Q2 2020 | $211,000 | -35.9% | 7,670 | -35.4% | 0.28% | +5.3% |
| Q4 2019 | $329,000 | +41.8% | 11,878 | -13.4% | 0.26% | +373.2% |
| Q1 2018 | $232,000 | – | 13,713 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |